Home › Relapsing-Remitting Multiple Sclerosis › Illinois › Chicago
Relapsing-Remitting Multiple Sclerosis clinical trials in Chicago, IL
5 studies for Relapsing-Remitting Multiple Sclerosis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
RecruitingPhase 3
- University of Chicago Medical Center, Chicago
Intermittent Hypoxia in Persons With Multiple Sclerosis
Recruiting
- Shirley Ryan AbilityLab, Chicago
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
RecruitingPhase 4
- Northwestern Memorial Hospital, Chicago
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Recruiting
- Shirley Ryan AbilityLab, Chicago
Home Based Functional Balance Intervention for Multiple Sclerosis
Recruiting
- University of Illinois at Chicago, Chicago
Relapsing-Remitting Multiple Sclerosis trials in other cities
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.